胰岛素对2型糖尿病女性骨密度的影响:SWAN药物流行病学研究
这项纵向研究分析了SWAN队列中110名糖尿病女性,使用倾向性评分匹配比较胰岛素启用者与未启用者的骨密度年变化。中位随访5.4年,胰岛素使用组股骨颈骨密度丢失大于未使用组(-1.1% vs -0.77%,p=0.04),脊柱和全髋无显著差异。
要点
- 胰岛素启用与股骨颈骨密度丢失更大相关(-1.1% vs -0.77%,p=0.04)。
- 脊柱和全髋骨密度丢失在两组间无显著差异。
- 研究为纵向观察性设计,中位随访5.4年。
核心结论
- 在2型糖尿病女性中,启用胰岛素者股骨颈骨密度丢失比未启用者更快。
研究设计与样本
- 纵向研究,纳入SWAN队列中110名糖尿病女性,采用倾向性评分匹配比较胰岛素启用组(n=55)与未启用组(n=55),中位随访5.4年。
主要发现
- 胰岛素使用组股骨颈骨密度丢失-1.1%,未使用组-0.77%(p=0.04)。
- 脊柱骨密度丢失两组分别为-0.30%与-0.32%(p=0.85)。
- 全髋骨密度丢失两组分别为-0.31%与-0.25%(p=0.71)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: This was a longitudinal study examining the effects of insulin use on bone mineral density loss. Insulin use was found to be associated with greater bone mineral density loss at the femoral neck among women with diabetes mellitus. INTRODUCTION: Women with diabetes mellitus (DM) have higher bone mineral density (BMD) and experience slower BMD loss but have an increased risk of fracture. The data regarding the effect of insulin treatment on BMD remains conflicted. We examined the impact of insulin initiation on BMD. METHODS: We investigated the annual changes in BMD associated with the new use of insulin among women with DM in the Study of Women's Health Across the Nation (SWAN). Propensity score (PS) matching, which is a statistical method that helps balance the baseline characteristics of women who did and did not initiate insulin, was used. Covariates with a potential impact on bone health were included in all models. Mixed model regression was used to test the change in BMD between the two groups. Median follow-up time was 5.4 years. RESULTS: The cohort consisted of 110 women, mean age, 53.6 years; 49% white and 51% black. Women using insulin (n = 55) were similar on most relevant characteristics to the 55 not using insulin. Median diabetes duration for the user group was 10 vs. 5.0 years for the non-user group. There was a greater loss of BMD at the femoral neck among insulin users (- 1.1%) vs non-users (- 0.77%) (p = 0.04). There were no differences in BMD loss at the spine - 0.30% vs - 0.32% (p = 0.85) or at the total hip - 0.31% vs - 0.25 (p = 0.71), respectively. CONCLUSIONS: Women with T2DM who initiated insulin experienced a more rapid BMD loss at the femoral neck as compared to women who did use insulin.
引用
- Ruppert K, Cauley J, Lian Y, et al. The effect of insulin on bone mineral density among women with type 2 diabetes: a SWAN Pharmacoepidemiology study. Osteoporos Int. 2017. PMID: 29075805. doi:10.1007/s00198-017-4276-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。